# ALNYLAM PHARMACEUTICALS, INC. (ALNY) FY2026 YTD Q2 P&L / Income Statement

- Company: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0001178670-26-000062
- Page: https://plicit.ai/financials/alny/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/alny-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 2,458,123,000 US dollars
- **Cost of goods sold**: 505,781,000 US dollars
- **Gross profit (calculated)**: 1,952,342,000 US dollars
- **Operating expenses (calculated)**: 1,452,265,000 US dollars
- **Income (loss) from operations**: 500,077,000 US dollars
- **Total other expense, net**: negative 100,618,000 US dollars
- **Income (loss) before income taxes**: 399,459,000 US dollars
- **Provision for income taxes**: 28,974,000 US dollars
- **Net income (loss)**: 370,485,000 US dollars
- **Net revenues from collaborations**: 129,240,000 US dollars
- **Royalty revenue**: 120,647,000 US dollars
- **Amvuttra - Rest of World**: 157,737,000 US dollars
- **Amvuttra - UNITED STATES**: 1,511,633,000 US dollars
- **Amvuttra - Europe**: 232,323,000 US dollars
- **GIVLAARI - Rest of World**: 12,454,000 US dollars
- **GIVLAARI - UNITED STATES**: 107,091,000 US dollars
- **GIVLAARI - Europe**: 44,613,000 US dollars
- **ONPATTRO - Rest of World**: 5,840,000 US dollars
- **ONPATTRO - UNITED STATES**: 20,029,000 US dollars
- **ONPATTRO - Europe**: 13,073,000 US dollars
- **OXLUMO - Rest of World**: 20,865,000 US dollars
- **OXLUMO - UNITED STATES**: 35,510,000 US dollars
- **OXLUMO - Europe**: 47,068,000 US dollars
- **Cost of collaborations and royalties**: 3,792,000 US dollars
- **Research and development**: 778,000,000 US dollars
- **Selling, general and administrative**: 670,473,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Counterparty Name

- Page: https://plicit.ai/financials/alny/fy2026-ytd-q2-income-statement/revenue-by-counterparty-name
- Chart image: https://plicit.ai/charts/alny-fy2026-ytd-q2-revenue-by-counterparty-name-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Counterparty Name. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 2,458,123,000 US dollars
- **Cost of goods sold**: 505,781,000 US dollars
- **Gross profit (calculated)**: 1,952,342,000 US dollars
- **Operating expenses (calculated)**: 1,452,265,000 US dollars
- **Income (loss) from operations**: 500,077,000 US dollars
- **Total other expense, net**: negative 100,618,000 US dollars
- **Income (loss) before income taxes**: 399,459,000 US dollars
- **Provision for income taxes**: 28,974,000 US dollars
- **Net income (loss)**: 370,485,000 US dollars
- **Other**: 355,000 US dollars
- **Regeneron Pharmaceuticals**: 51,356,000 US dollars
- **Roche**: 77,529,000 US dollars
- **Net product revenues**: 2,208,236,000 US dollars
- **Royalty revenue**: 120,647,000 US dollars
- **Cost of collaborations and royalties**: 3,792,000 US dollars
- **Research and development**: 778,000,000 US dollars
- **Selling, general and administrative**: 670,473,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (6 categories)

- Page: https://plicit.ai/financials/alny/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-6-categories
- Chart image: https://plicit.ai/charts/alny-fy2026-ytd-q2-revenue-by-product-and-service-6-categories-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Product and service (6 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 2,458,123,000 US dollars
- **Cost of goods sold**: 505,781,000 US dollars
- **Gross profit (calculated)**: 1,952,342,000 US dollars
- **Operating expenses (calculated)**: 1,452,265,000 US dollars
- **Income (loss) from operations**: 500,077,000 US dollars
- **Total other expense, net**: negative 100,618,000 US dollars
- **Income (loss) before income taxes**: 399,459,000 US dollars
- **Provision for income taxes**: 28,974,000 US dollars
- **Net income (loss)**: 370,485,000 US dollars
- **GIVLAARI**: 164,158,000 US dollars
- **OXLUMO**: 103,443,000 US dollars
- **Amvuttra**: 1,901,693,000 US dollars
- **ONPATTRO**: 38,942,000 US dollars
- **Net revenues from collaborations**: 129,240,000 US dollars
- **Royalty revenue**: 120,647,000 US dollars
- **Cost of collaborations and royalties**: 3,792,000 US dollars
- **Research and development**: 778,000,000 US dollars
- **Selling, general and administrative**: 670,473,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (3 categories)

- Page: https://plicit.ai/financials/alny/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-3-categories
- Chart image: https://plicit.ai/charts/alny-fy2026-ytd-q2-revenue-by-product-and-service-3-categories-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 2,458,123,000 US dollars
- **Cost of goods sold**: 505,781,000 US dollars
- **Gross profit (calculated)**: 1,952,342,000 US dollars
- **Operating expenses (calculated)**: 1,452,265,000 US dollars
- **Income (loss) from operations**: 500,077,000 US dollars
- **Total other expense, net**: negative 100,618,000 US dollars
- **Income (loss) before income taxes**: 399,459,000 US dollars
- **Provision for income taxes**: 28,974,000 US dollars
- **Net income (loss)**: 370,485,000 US dollars
- **Net product revenues**: 2,208,236,000 US dollars
- **Net revenues from collaborations**: 129,240,000 US dollars
- **Royalty revenue**: 120,647,000 US dollars
- **Cost of collaborations and royalties**: 3,792,000 US dollars
- **Research and development**: 778,000,000 US dollars
- **Selling, general and administrative**: 670,473,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.